Best Cervical Cancer Doctors in Hyderabad — CION's Dedicated Cervical Cancer Panel

The best doctor for cervical cancer is a gynae-oncologist (surgical oncologist with subspecialty training in gynaecologic oncology) for surgical management, paired with a radiation oncologist experienced in cervical cancer brachytherapy for radiation, and a medical oncologist for chemotherapy and immunotherapy. At CION, every cervical cancer case is reviewed by a multidisciplinary tumour board, with surgical leadership by Dr. Paila Gowri Naidu (M.Ch Surgical Oncology, BHU Varanasi) — a female specialist with gynae-onc subspecialty training.

For some early-stage cervical cancers (typically Stage IA–IB1, tumours less than 2–4 cm, with no high-risk features), fertility-preserving surgery — radical trachelectomy — is possible. This removes the cervix and surrounding tissue while preserving the uterus, allowing future pregnancy. Radical trachelectomy is highly specialised and requires gynae-oncology subspecialty expertise. At CION, this option is evaluated at the first consultation for eligible patients. For patients facing chemoradiation or where fertility-preserving surgery is not feasible, fertility preservation through ovarian transposition (moving ovaries out of the radiation field) or oocyte preservation may be coordinated with accredited reproductive medicine partners before treatment begins.

Yes — brachytherapy is central to cervical cancer cure, and CION's radiation oncology pathway includes brachytherapy delivered at our main hospital partner locations. External beam radiation therapy (EBRT) delivers radiation from outside the body and treats the pelvis broadly. Brachytherapy delivers radiation from inside — a source is placed temporarily in the cervix and vagina — and delivers a much higher dose to the tumour while sparing surrounding organs. For locally advanced cervical cancer (Stage IIB–IVA), the combination of concurrent cisplatin chemotherapy + EBRT + brachytherapy is the curative standard of care. Centres without brachytherapy capability cannot deliver curative treatment for locally advanced cervical cancer — this is a meaningful difference between centres.

A general gynaecologist often diagnoses cervical cancer through Pap smear, colposcopy, and biopsy. Once cancer is confirmed, treatment must be led by oncology — specifically, a gynae-oncologist for surgical management. A gynae-oncologist has subspecialty training (M.Ch or DM in Gynaecologic Oncology) distinct from general gynaecology, and performs radical hysterectomy, radical trachelectomy, and pelvic lymphadenectomy with onco-specific technique. A general gynaecologist performing radical cancer surgery without gynae-onc training has meaningfully different outcomes.

Yes — cervical cancer is one of the cancers most comprehensively covered by the Aarogyasri scheme in Telangana. Eligible patients receive coverage for diagnostic workup, surgery (radical hysterectomy, lymphadenectomy), chemoradiation including brachytherapy, and follow-up care. CION is Aarogyasri-empanelled, and our family financial counsellor will walk you through eligibility, documentation, and the approval pathway at the first consultation. EMI and cashless insurance are also accepted for patients not eligible for Aarogyasri.

Yes — more than 99% of cervical cancers are caused by persistent infection with high-risk strains of human papillomavirus (HPV), most commonly HPV-16 and HPV-18. HPV infection is extremely common — most sexually active adults are exposed at some point — and most clear the infection without ever developing cancer. In a small percentage, persistent infection over many years causes cellular changes (CIN 1, 2, 3) that may eventually progress to cancer. This is not a reflection on you or your behaviour. The HPV vaccine, given before exposure (ideally in early adolescence), can prevent most cervical cancers — and is increasingly recommended in India. Your daughters and other young women in your family should consider HPV vaccination.

It depends on the stage and your fertility goals. For very early-stage cervical cancer (Stage IA1), conization (removal of cone-shaped tissue from the cervix) may be sufficient, preserving both uterus and fertility. For Stage IA2–IB1 in younger women who want to preserve fertility, radical trachelectomy (removing the cervix but keeping the uterus) is an option. For most other early-stage cases, radical hysterectomy (removing uterus, cervix, upper vagina, and surrounding tissue) is the standard. For locally advanced disease (Stage IIB and above), chemoradiation is the curative treatment — surgery is not typically performed. The right decision depends on stage, tumour size, your age, and your fertility plans, discussed in detail at the first consultation.

Cervical cancer treatment can affect sexual function — radiation can cause vaginal stenosis (narrowing) and dryness; radical hysterectomy can affect sensation and lubrication; chemotherapy can cause early menopause in pre-menopausal patients. These effects are real and should be discussed openly. Modern treatment minimises these effects where possible (IMRT-based radiation, nerve-sparing radical hysterectomy where feasible), and supportive care — vaginal dilators, lubricants, hormonal therapy where appropriate, and counselling — is part of the CION pathway. Many women resume satisfactory sexual function after treatment with appropriate support.

A second opinion is especially valuable for cervical cancer — both because surgery vs chemoradiation decisions vary across centres, and because fertility preservation options may not be discussed at every centre. At CION the second opinion is free, written, and yours to keep — our multidisciplinary tumour board reviews your biopsy, imaging, and existing recommendation and provides a documented opinion you can take anywhere.

Costs vary by stage and treatment, but Aarogyasri covers a substantial portion of cervical cancer treatment in Telangana. Radical hysterectomy ranges approximately ₹1,50,000 to ₹3,00,000; concurrent chemoradiation including brachytherapy ranges ₹3,00,000 to ₹6,00,000; pembrolizumab immunotherapy for advanced disease is significantly higher per cycle. For a detailed cost breakdown by treatment type, see our cervical cancer treatment in Hyderabad page. Every CION patient receives a written, itemised cost estimate before treatment begins, with Aarogyasri eligibility checked upfront. EMI and cashless insurance also accepted.